(Q44136733)

English

Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies.

scientific article published in September 2002

Statements

Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit